These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34591335)

  • 1. Repurposing fusion inhibitor peptide against SARS-CoV-2.
    Efaz FM; Islam S; Talukder SA; Akter S; Tashrif MZ; Ali MA; Sufian MA; Parves MR; Islam MJ; Halim MA
    J Comput Chem; 2021 Dec; 42(32):2283-2293. PubMed ID: 34591335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    Bi W; Chen G; Dang B
    J Virol; 2022 Jul; 96(13):e0068122. PubMed ID: 35735997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2.
    Ling R; Dai Y; Huang B; Huang W; Yu J; Lu X; Jiang Y
    Peptides; 2020 Aug; 130():170328. PubMed ID: 32380200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Mondal S; Karmakar A; Mallick T; Begum NA
    Virology; 2021 Apr; 556():133-139. PubMed ID: 33571798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
    Xia S; Liu M; Wang C; Xu W; Lan Q; Feng S; Qi F; Bao L; Du L; Liu S; Qin C; Sun F; Shi Z; Zhu Y; Jiang S; Lu L
    Cell Res; 2020 Apr; 30(4):343-355. PubMed ID: 32231345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.
    Zheng M; Cong W; Peng H; Qing J; Shen H; Tang Y; Geng C; Chen S; Zou Y; Zhang WD; Hu HG; Li X
    J Med Chem; 2021 Dec; 64(23):17486-17495. PubMed ID: 34818014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.
    Xia S; Lan Q; Zhu Y; Wang C; Xu W; Li Y; Wang L; Jiao F; Zhou J; Hua C; Wang Q; Cai X; Wu Y; Gao J; Liu H; Sun G; Münch J; Kirchhoff F; Yuan Z; Xie Y; Sun F; Jiang S; Lu L
    Signal Transduct Target Ther; 2021 Jul; 6(1):288. PubMed ID: 34326308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life.
    Duan Q; Xia S; Jiao F; Wang Q; Wang R; Lu L; Jiang S; Xu W
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
    Singh I; Singh S; Ojha KK; Yadav NS
    J Biomol Struct Dyn; 2022; 40(21):11357-11372. PubMed ID: 34379031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides Derived from the SARS-CoV-2 S2-Protein Heptad-Repeat-2 Inhibit Pseudoviral Fusion at Micromolar Concentrations: The Role of Palmitic Acid Conjugation.
    Düzgüneş N; Tao Z; Zhang Y; Krajewski K
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis.
    Rodal Canales FJ; Pérez-Campos Mayoral L; Hernández-Huerta MT; Sánchez Navarro LM; Matias-Cervantes CA; Martínez Cruz M; Cruz Parada E; Zenteno E; Ramos-Martínez EG; Pérez-Campos Mayoral E; Romero Díaz C; Pérez-Campos E
    Sci Rep; 2021 Nov; 11(1):22288. PubMed ID: 34782703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Yang K; Wang C; Kreutzberger AJB; Ojha R; Kuivanen S; Couoh-Cardel S; Muratcioglu S; Eisen TJ; White KI; Held RG; Subramanian S; Marcus K; Pfuetzner RA; Esquivies L; Doyle CA; Kuriyan J; Vapalahti O; Balistreri G; Kirchhausen T; Brunger AT
    Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2210990119. PubMed ID: 36122200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.
    Jiao F; Andrianov AM; Wang L; Furs KV; Gonchar AV; Wang Q; Xu W; Lu L; Xia S; Tuzikov AV; Jiang S
    J Med Virol; 2023 Oct; 95(10):e29145. PubMed ID: 37804480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases.
    Lan Q; Wang L; Jiao F; Lu L; Xia S; Jiang S
    J Med Virol; 2023 Jan; 95(1):e28143. PubMed ID: 36098460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2.
    Panda SK; Sen Gupta PS; Biswal S; Ray AK; Rana MK
    J Proteome Res; 2021 Feb; 20(2):1296-1303. PubMed ID: 33472369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.
    Xia S; Yan L; Xu W; Agrawal AS; Algaissi A; Tseng CK; Wang Q; Du L; Tan W; Wilson IA; Jiang S; Yang B; Lu L
    Sci Adv; 2019 Apr; 5(4):eaav4580. PubMed ID: 30989115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins.
    Polo-Megías D; Cano-Muñoz M; Berruezo AG; Laumond G; Moog C; Conejero-Lara F
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.